About 3 results found for searched term "Inotuzumab" (0.628 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M24778 | Inotuzumab | Others |
| Humanized Anti-CD22 Recombinant Antibody | ||
| Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) is a humanized IgG4, κ antibody that targets human CD22. Inotuzumab can be linked to a toxic agent ozogamicin as an antibody-drug conjugate (ADC). Inotuzumab can be used for the research of acute lymphoblastic leukemia and non-Hodgkin lymphoma. | ||
| M40545 | Inotuzumab Ozogamicin | ADC Linker |
| Inotuzumab Ozogamicin is an antibody-drug concatenation (ADC) containing an anti-CD22 monoclonal antibody as well as spinosad for studies related to acute lymphoblastic leukemia (ALL). | ||
| M59136 | Inotuzumab MMAE | Antibody-Drug Conjugates (ADCs) |
| Inotuzumab MMAE is an anti-CD22 antibody-drug conjugate (ADC). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
